^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Bladder Cancer |
| Regimen: | ddMVAC (cisplatin + doxorubicin hydrochloride + + vinblastine) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
10/26/2021
Excerpt:
Bladder Cancer…Preferred regimen…DDMVAC (dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin) with growth factor support for 3-6 cycles
